41° and Sunny
$3.5 Million in Cancer Research Grants Awarded Across New Jersey
The New Jersey Commission on Cancer Research (NJCCR) funds 21 peer-reviewed projects, supporting groundbreaking cancer research at qualified institutions.
NEW JERSEY – In a monumental effort to accelerate cancer research, the NJCCR has granted nearly $3.5 million in funding for Fiscal Year 2023. The grants will fund 21 diverse research initiatives ranging from pancreatic tumor studies to pediatric cancer investigations, advancing the mission of fighting cancer at the genetic, cellular, and community levels.
The 11-member NJCCR, New Jersey's exclusive cancer commission, remains devoted to backing basic, translational, fellowships, and pilot cancer research grants. Over decades, NJCCR has awarded more than $52 million for 915 peer-reviewed grants and fellowships, laying the foundation for innovation from laboratory studies to bedside applications.
By investing in research, NJCCR secures the future of scientists in New Jersey, supporting the next generation of researchers. This aligns with the Commission's 40-year mission to promote significant research into cancer causes, prevention, and treatment.
In this funding cycle, a wide range of research grants have been awarded:
- Pilot Research Grants: Dr. Brett Ecker and Dr. Subhajyoti De received $200,000 for the evaluation of pancreatic cystic neoplasms at Rutgers Cancer Institute. Dr. Racquel "Kelly" Kohler was awarded $182,495 for a study on anal cancer screening among people living with HIV in New Jersey.
- Predoctoral Fellowships: Several researchers received $100,000 each for projects at Rutgers University and Princeton University, investigating topics such as chemotherapy-induced cognitive impairment, leukemia therapeutic targets, and immune activation for cancer immunotherapy.
- Postdoc Fellowships: Researchers including Dr. Amartya Singh and Dr. Jianming Wang received $200,000 for projects on transcriptomics analysis and targeting intestinal epithelium-immune cell interactions in colorectal cancer.
- Pediatric Research Grants: Dr. Beth Savage received $198,450 for studying poverty's impact on childhood ALL symptoms, while Dr. Mi-Hyeon Jang was awarded $200,000 for identifying chemobrain biomarkers in pediatric patients.
A complete list of the awardees, mentors, and projects can be found on the NJCCR's website.
Established in 1983 by P.L. 83, c. 6, also known as the Cancer Research Act, the NJCCR celebrates its 40th anniversary this year. Its ongoing dedication to cancer research resonates as a beacon of hope for patients, providers, and researchers.
The awards represent a significant step in New Jersey's ongoing battle against cancer. By empowering scientists and institutions with essential funding, the state reinforces its commitment to finding innovative solutions to cancer's complex challenges. These grants are more than just financial support; they are an investment in a healthier future for all New Jersey residents.
For more information on the commission and details of the funded projects, visit www.nj.gov/health/ces/njccr.
